Search Results - Brian Lerman
- Showing 1 - 1 results of 1
-
1
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibo... by Juan Manuel Carreño, Brian Lerman, Gagandeep Singh, Anass Abbad, Temima Yellin, Jordan Ehrenhaus, Miriam Fried, Jessica R. Nardulli, Hyun Min Kang, Lubbertus C. F. Mulder, Charles Gleason, Komal Srivastava, Viviana Simon, Florian Krammer
Published in mBio (2025-04-01)Get full text
Article
